| 标题 |
[求助补充材料]
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Nadia Harbeck; Chiun‐Sheng Huang; Sara A. Hurvitz; Dah‐Cherng Yeh; Zhimin Shao; et al 出版日期:2016-01-25 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)